Biomarkers Can Predict Type 2 Diabetes Two Decades Before the Diagnosis
For some time, diabetes
has been a dangerous chronic illness in the US. And
the disease has received a lot of attention. In
recent years, prediabetes has also received a great
deal of attention. Prediabetes has been given
attention because it is often the forerunner of type
2 diabetes. Approximately 30 million Americans have
type 2 diabetes, and over 84 million Americans have
prediabetes. But luckily, there are biomarkers that
can predict type 2 diabetes as much as two decades
before a person is diagnosed with the disease. And
there are proven lifestyle changes and medications
that can help one delay or avoid type 2 diabetes.
In a Japanese study, 27,392 adults who did not have diabetes were studied. They were looked at between the years of 2005 and 2016. At the start of the study, blood glucose and weight were measured. During the 11 year period, 1067 of the subjects developed type 2 diabetes. The researchers concluded that since “the vast majority of people with type 2 diabetes go through the stage of prediabetes, [the researchers'] findings suggest that elevated metabolic markers for diabetes are detectable more than 20 years before its diagnosis.”
Another study, done in Sweden, also demonstrated that risk factors for type 2 diabetes exist up to 20 years before one is diagnosed with the disease. The study followed 296,439 individuals who were nondiabetic for 20 years. During that time about 10% of the study subjects received a diagnosis of type 2 diabetes. In looking at the biomarkers, BMI, triglycerides, and fasting glucose, it was revealed that those persons who had these biomarkers at higher than normal levels were at a higher risk of type 2 diabetes, about 20 years later.
Fortunately, intensive lifestyle intervention (ILI) and medication can help avoid or prevent type 2 diabetes after one is diagnosed with prediabetes. In one study where 422 adults in Southern California were examined, it was found that ILI or ILI in combination with medications can help individuals avoid type 2 diabetes. The researchers concluded that “after an average follow-up period of almost 3 years, the annual rate of transitioning to full diabetes was 4.1% among people who received only lifestyle therapy, and 1.7% in patients on two diabetes drugs.”
Further, “none of the patients on three diabetes drugs develop diabetes.” Patients in the study who received prescriptions for two medications were on metformin and another diabetes medication. And patients on three medications were on metformin and pioglitazone and another diabetes medication, including exenatide and liraglutide.
So clinicians should be aware that predicting diabetes is possible. And delaying or avoiding type 2 diabetes is also possible. Knowing this can help clinicians better treat patients who are at high risk of type 2 diabetes.
In a Japanese study, 27,392 adults who did not have diabetes were studied. They were looked at between the years of 2005 and 2016. At the start of the study, blood glucose and weight were measured. During the 11 year period, 1067 of the subjects developed type 2 diabetes. The researchers concluded that since “the vast majority of people with type 2 diabetes go through the stage of prediabetes, [the researchers'] findings suggest that elevated metabolic markers for diabetes are detectable more than 20 years before its diagnosis.”
Another study, done in Sweden, also demonstrated that risk factors for type 2 diabetes exist up to 20 years before one is diagnosed with the disease. The study followed 296,439 individuals who were nondiabetic for 20 years. During that time about 10% of the study subjects received a diagnosis of type 2 diabetes. In looking at the biomarkers, BMI, triglycerides, and fasting glucose, it was revealed that those persons who had these biomarkers at higher than normal levels were at a higher risk of type 2 diabetes, about 20 years later.
Fortunately, intensive lifestyle intervention (ILI) and medication can help avoid or prevent type 2 diabetes after one is diagnosed with prediabetes. In one study where 422 adults in Southern California were examined, it was found that ILI or ILI in combination with medications can help individuals avoid type 2 diabetes. The researchers concluded that “after an average follow-up period of almost 3 years, the annual rate of transitioning to full diabetes was 4.1% among people who received only lifestyle therapy, and 1.7% in patients on two diabetes drugs.”
Further, “none of the patients on three diabetes drugs develop diabetes.” Patients in the study who received prescriptions for two medications were on metformin and another diabetes medication. And patients on three medications were on metformin and pioglitazone and another diabetes medication, including exenatide and liraglutide.
So clinicians should be aware that predicting diabetes is possible. And delaying or avoiding type 2 diabetes is also possible. Knowing this can help clinicians better treat patients who are at high risk of type 2 diabetes.
-------------------------------------------------------
Tags: , ,
Tags: , ,
posted by Information Uncover at
6:22 PM
Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home